Filing Details
- Accession Number:
- 0001104659-19-041623
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-24 17:28:30
- Reporting Period:
- 2019-07-22
- Accepted Time:
- 2019-07-24 17:28:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1192448 | Glaukos Corp | GKOS | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1705850 | E Joseph Gilliam | C/O Glaukos Corporation, 229 Avenida Fabricante San Clemente CA 92672 | Cfo, Svp Corporate Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-07-22 | 6,250 | $41.69 | 53,778 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-07-22 | 2,294 | $74.91 | 51,481 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-07-22 | 3,956 | $75.70 | 47,528 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-07-22 | 4,096 | $30.92 | 51,624 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-07-22 | 1,556 | $74.92 | 50,068 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-07-22 | 2,540 | $75.69 | 47,528 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2019-07-22 | 6,250 | $0.00 | 6,250 | $41.69 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2019-07-22 | 4,096 | $0.00 | 4,096 | $30.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 169,343 | 2027-05-05 | No | 4 | M | Direct | |
| 46,449 | 2028-03-14 | No | 4 | M | Direct |
Footnotes
- Includes 37,853 restricted stock units that have not yet vested or been delivered to the Reporting Person, and 465 shares acquired under the Issuer's Employee Stock Purchase Plan in July 2019.
- These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices.
- This transaction was executed in multiple trades at prices ranging from $74.35 to $75.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $75.43 to $75.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $74.35 to $75.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $75.43 to $75.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.
Billionaire Hedge Funds
